Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Geriatr Soc. 2009 Mar;57(3):476-81. doi: 10.1111/j.1532-5415.2008.02147.x. Epub 2009 Jan 23.

Long-term effect on mortality of a home intervention that reduces functional difficulties in older adults: results from a randomized trial.

Author information

  • 1Jefferson Center for Applied Research on Aging and Health, Thomas Jefferson University, Philadelphia, Pennsylvania 19130, USA. laura.gitlin@jefferson.edu

Abstract

OBJECTIVES:

To evaluate the long-term mortality effect of a home-based intervention previously shown to reduce functional difficulties and whether survivorship benefits differ according to initial mortality risk level.

DESIGN:

Two-group randomized trial with survivorship followed up to 4 years from study entry.

SETTING:

Homes of urban community-living elderly people.

PARTICIPANTS:

Three hundred nineteen adults aged 70 and older with difficulties performing daily activities.

INTERVENTION:

Occupational and physical therapy sessions to instruct participants in compensatory strategies, home modifications, home safety, fall recovery techniques, and balance and muscle strength exercises.

MEASUREMENTS:

Survival time was number of days between baseline interview and date of death, as determined using data from the National Death Index or December 31, 2005. Participants were stratified according to baseline mortality risk (low, moderate, high) using a prognostic indicator.

RESULTS:

At 2 years, intervention participants (n=160) had a 5.6% mortality rate (n=9 deaths) and controls (n=159) a 13.2% rate (n=21 deaths; P=.02). Mortality rates remained lower for intervention participants up to 3.5 years from study entry. At 2 years, intervention participants with moderate mortality risk had a 16.7% mortality rate (n=16 deaths/96), compared with 28.2% for equivalent control group participants (n=24 deaths/85; P=.02). By 3 years, mortality rates were not statistically significantly different between the experimental and control groups.

CONCLUSIONS:

The intervention extended survivorship up to 3.5 years and maintained statistically significant differences for 2 years. Subjects at moderate mortality risk derived the most intervention benefit. Findings suggest that the intervention could be a low-cost clinical tool to delay functional decline and mortality.

Comment in

PMID:
19187417
[PubMed - indexed for MEDLINE]
PMCID:
PMC2712136
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing Icon for PubMed Central
    Loading ...
    Write to the Help Desk